- 數(shù)據(jù)庫(kù)收錄SCIE
- 年發(fā)文量64
Middle East Journal Of Cancer
期刊中文名：中東癌癥雜志ISSN：2008-6709E-ISSN：2008-6687
該雜志國(guó)際簡(jiǎn)稱：MIDDLE EAST J CANCER，是由出版商Shiraz University of Medical Sciences出版的一本致力于發(fā)布--研究新成果的的專業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果，扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展，選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論，促進(jìn)學(xué)術(shù)發(fā)展，為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有很高的學(xué)術(shù)影響力。
雜志介紹
Middle East Journal Of Cancer雜志介紹
《Middle East Journal Of Cancer》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱中東癌癥雜志，本刊主要出版、報(bào)道領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為0.4，最新CiteScore 指數(shù)為0.8。
英文介紹
Middle East Journal Of Cancer雜志英文介紹
The Middle East Journal of Cancer (MEJC) is an internationally peer-reviewed journal dedicated to publishing high-quality basic science and clinical research papers. This magazine covers a wide range of fields in cancer research, including cancer cell biology, cancer genetics, tumor virology, tumor immunology, cancer treatment, as well as epidemiology and cancer prevention. MEJC aims to promote the progress of cancer research in the Middle East and even globally, and provide a platform for researchers to publish and exchange the latest research results.
Its characteristic lies in its comprehensive coverage of cancer research, especially in the Middle East region. This journal emphasizes the publication of research that can arouse interdisciplinary interest and encourages the submission of technically solid and experimentally detailed papers. MEJC's academic positioning is to become one of the authoritative journals in the field of cancer research, providing high impact research results for scientists and medical professionals worldwide. In addition, it is of great significance to the cancer research community, as it not only provides a platform for publishing research, but also helps to promote the translation of scientific discoveries into clinical practice. By publishing research from different regions, MEJC has promoted collaboration and knowledge sharing in global cancer research, which has had a positive impact on improving global cancer management.
JCR分區(qū)（2023-2024年最新版）
Middle East Journal Of Cancer雜志 JCR分區(qū)信息
| 按JIF指標(biāo)學(xué)科分區(qū) |
學(xué)科：ONCOLOGY
收錄子集：ESCI
分區(qū)：Q4
排名：304 / 322
百分位：
5.7% |
| 按JCI指標(biāo)學(xué)科分區(qū) |
學(xué)科：ONCOLOGY
收錄子集：ESCI
分區(qū)：Q4
排名：307 / 322
百分位：
4.81% |
JCR分區(qū)：JCR分區(qū)來(lái)自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具，為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū)，設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū)，分別為Q1、Q2、Q3和Q4，各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。
CiteScore 評(píng)價(jià)數(shù)據(jù)（2024年最新版）
Middle East Journal Of Cancer雜志CiteScore 評(píng)價(jià)數(shù)據(jù)
- CiteScore 值：0.8
- SJR：0.229
- SNIP：0.193
| 學(xué)科類別 | 分區(qū) | 排名 | 百分位 |
| 大類：Medicine 小類：Oncology | Q4 | 319 / 404 |
21% |
| 大類：Medicine 小類：Cancer Research | Q4 | 198 / 230 |
13% |
歷年影響因子和期刊自引率
投稿經(jīng)驗(yàn)
Middle East Journal Of Cancer雜志投稿經(jīng)驗(yàn)
該雜志是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有較高的學(xué)術(shù)影響力，行業(yè)關(guān)注度很高，已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高，對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高，作為一本國(guó)際優(yōu)秀雜志，一般投稿過(guò)審時(shí)間都較長(zhǎng)，投稿過(guò)審時(shí)間平均 12 Weeks ，如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單，建議您投稿。如您想了解更多投稿政策及投稿方案，請(qǐng)咨詢客服。
免責(zé)聲明
若用戶需要出版服務(wù)，請(qǐng)聯(lián)系出版商。